𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in hepatitis A prevention in travellers

✍ Scribed by Professor R. Steffen; D. Gyurech

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
316 KB
Volume
44
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The introduction of an active vaccine against hepatitis A, the most frequent of the vaccinepreventable infections in travellers, is an important contribution to travellers' health. Although theoretically the risk of exposure may be minimised by taking hygienic precautions, most travellers in practice remain at considerable risk. As compared to immunoglobulin, vaccine has the advantages of better and long‐lasting protection. A double‐strength vaccine has been introduced (HAVRIX(tm), 1440 enzyme‐linked immunosorbent [ELISA] units [EL. U]) and a single injection will protect from day 14 for 1 year. No significant adverse events have been reported. Questions that remain unanswered are whether travellers leaving before day 14 should receive immune globulin plus vaccine and whether very young travellers should all be immunised. Β© 1994 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Prevalence of hepatitis a antibodies in
Prevalence of hepatitis a antibodies in Swiss travellers
✍ S. Studer; H. I. Joller-Jemelka; R. Steffen; P. J. Grob πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 379 KB

To assess the prevalence of antibodies to hepatitis A virus (anti-HAV) in future travellers, all visitors to the Zurich University Vaccination Center in July/August 1990 were invited to participate in a cross-sectional study. A total of 1126 future travellers were recruited to have a blood sample dr

Cost-effectiveness analysis of vaccinati
Cost-effectiveness analysis of vaccination against hepatitis A in travellers
✍ E. van Doorslaer; G. Tormans; P. van Damme πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 605 KB

## Abstract Hepatitis A virus (HAV) infection is a substantial risk for travellers from low endemic countries to high endemic destinations. Costs and effects of alternative options for prevention were compared using formal decision analysis. General indications for the optimal prevention of hepatit

Recent advances in hepatic resection
Recent advances in hepatic resection
✍ Ronald P. Dematteo; Yuman Fong; William R. Jarnagin; Leslie H. Blumgart πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 336 KB πŸ‘ 2 views

Hepatic surgery has emerged over the last three decades and has proven to be a safe and effective treatment for primary and secondary malignancies, as well as for benign diseases of the liver. During the past 10 years, several major advances have been made in 1) surgical technique with the advent of

Prevention and control of hepatitis B in
Prevention and control of hepatitis B in China
✍ Zongtang Sun; Lihua Ming; Xu Zhu; Jianhua Lu πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 59 KB

## Abstract About 170 million Chinese are infected chronically with HBV and 10% suffer from chronic hepatitis. Around half a million Chinese die from hepatitis B caused hepatocellular carcinoma and endstage cirrhosis each year. From 1983 to the present, a controlled clinical trial involving 80,000